Neoprobe Corporation (NYSE Amex: NEOP) reached up 11.86% in morning trading to $2.94 with 650K shares traded. Neoprobe Corporation is a biomedical company focused on enhancing oncology patient care and improving patient benefit through radiopharmaceutical product development. Neoprobe is actively developing two radiopharmaceutical agent platforms – Lymphoseek® and RIGScanTM CR – to help surgeons better identify and treat certain types of cancer. Neoprobe’s subsidiary, Cira Biosciences, Inc., is also exploring development of a patient-specific cellular therapy technology platform called ACT. Neoprobe’s strategy is to deliver superior growth and shareholder return by bringing to market novel radiopharmaceutical agents and advancing the Company’s pipeline program through continued investment and selective acquisitions. Neoprobe Corporation (NYSE Amex: NEOP) yesterday announced that its New Drug Application (NDA) for Lymphoseek® (tilmanocept) has been accepted for review by the U.S. Food and Drug Administration (FDA). Neoprobe submitted the Lymphoseek NDA on August 10, 2011.
Pervasip Corp.'s (OTCQB:PVSP) reached up 12.50% in morning trading to $.009 with 640K shares traded. Pervasip is a new generation communications company providing wholesale and retail Voice over Internet Protocol (VoIP) services. Pervasip is focusing its resources on the growth of its wholly owned subsidiary, VoX Communications. Using its own nationwide VoIP network, VoX offers scalable and reliable broadband voice, origination and termination services to cable, wireless and wireline operators, as well as enhanced VoIP telephone service to the small business and residential marketplaces. VoX's proprietary IP platform enables superior quality and service at very low fixed costs, which is expected to translate into a faster break even threshold as the Company capitalizes on accelerating market demand for its VoIP services. Pervasip Corp.'s (OTCQB:PVSP) wholly owned subsidiary, VoX Communications (VoX) today announced that Barry MacCheyne, a former sales executive from Global Crossing and Tata Communications, has joined the company as the Chief Marketing Officer. Mr. MacCheyne, who brings over 20 years of sales and marketing experience to VoX, will be responsible for global sales and marketing of the VoX voice and video products.
China Nuvo Solar Energy, Inc. (OTCQB: CNUV) reached up 25% in morning trading to $.0015 with 25M shares traded. China Nuvo Solar Energy, Inc. is a development stage company that owns unique patent pending solar and photovoltaic related technology. The Company is also seeking other business opportunities. China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that The State of Nevada has approved the Company's requested corporate name change to SurgLine International, Inc. ("SI" or "Parent"). Majority shareholders recently approved and authorized the Board of Directors to change the Company's name. SurgLine, Inc. will remain as a wholly owned subsidiary of the Parent. As a result of the Nevada approval, the Company will file with the appropriate regulatory bodies the name change as well as a new ticker symbol to better reflect the Company's core business. We will announce further details as the process and timing for the new name to be reflected in the markets as well as the new symbol as we go thru the regulatory process. Until then the Company will continue to trade under the symbol CNUV.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
